Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-21-082068

Options or other derivatives

  • Chief Medical Officer acquired 39,380 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2021-06-14 Grant or award · Restricted Stock Units +39,380 39,380 D: show line 1 in the form
Loading xslF345X03/tm2119923-3_4seq1.xml…